Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies

Heart disease is all relative, TapGenes makes it relatable

Get Involved in AHA-32-TapGenes
Claim This Profile →

Company Info

Categories

Cardiovascular DiseaseGenetic DisordersPrecision MedicinePatient EducationPrevention

Video

MedStartr Index Score

?
3

What do you think of AHA-32-TapGenes?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in AHA-32-TapGenes